| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/SYN.1082 |
| P698 | PubMed publication ID | 11418938 |
| P50 | author | Norihiro Harada | Q41909424 |
| P2093 | author name string | Takahashi K | |
| Sato K | |||
| Nishiyama S | |||
| Tsukada H | |||
| Kakiuchi T | |||
| Ohba H | |||
| P2860 | cites work | Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis | Q93519872 |
| THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS | Q26778400 | ||
| In vivo Muscarinic Cholingeric Receptor Imaging in Human Brain with [11C]Scopolamine and Positron Emission Tomography | Q28324314 | ||
| LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
| Alterations of brain neurotransmitter receptor binding in Huntington's chorea | Q31152135 | ||
| Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with | Q31949201 | ||
| Synthesis and autoradiographic localization of muscarinic cholinergic antagonist (+)N-[11C]methyl-3-piperidyl benzilate as a potent radioligand for positron emission tomography | Q33854541 | ||
| Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in [...] | Q33942589 | ||
| Deciphering Alzheimer's disease: the amyloid precursor protein yields new clues | Q37813340 | ||
| Age-related changes in multiple neurotransmitter systems in the monkey brain | Q38359656 | ||
| Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia | Q38666264 | ||
| The cholinergic hypothesis--ten years on. | Q39729362 | ||
| Cholinergic function and intellectual decline in Alzheimer's disease | Q39749652 | ||
| Cholinergic neurotransmission studied in vivo using positron emission tomography or single photon emission computerized tomography | Q40457662 | ||
| Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine | Q40904824 | ||
| Development and evaluation of muscarinic cholinergic receptor ligands N-[11C]ethyl-4-piperidyl benzilate and N-[11C]propyl-4-piperidyl benzilate: a PET study in comparison with N-[11C]methyl-4-piperidyl benzilate in the conscious monkey brain | Q43517576 | ||
| Effects of aging on serotonin transporter availability and its response to fluvoxamine in the living brain: PET study with [(11)C](+)McN5652 and [(11)C](-)McN5652 in conscious monkeys | Q43576713 | ||
| Mapping muscarinic receptors in human and baboon brain using [N-11C-methyl]-benztropine. | Q44489489 | ||
| Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding | Q47976364 | ||
| Synthesis of radiotracers for studying muscarinic cholinergic receptors in the living human brain using positron emission tomography: [11C]dexetimide and [11C]levetimide | Q48165529 | ||
| [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives | Q48198612 | ||
| Autoradiographic study of regional protein synthesis in focal cerebral ischemia with TCA wash and image subtraction techniques | Q48226757 | ||
| Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography | Q48346907 | ||
| Studies on muscarinic binding sites in human brain identified with [3H]pirenzepine | Q48422467 | ||
| Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging | Q48656933 | ||
| Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). | Q48853141 | ||
| Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection | Q48882699 | ||
| Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia | Q49016395 | ||
| In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate | Q49108576 | ||
| Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. | Q51429472 | ||
| Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey. | Q51620053 | ||
| Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. | Q53204038 | ||
| Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches | Q68805724 | ||
| Muscarinic and dopaminergic receptors in the aging human brain | Q68984610 | ||
| Routine synthesis of N-[11C-methyl]scopolamine by phosphite mediated reductive methylation with [11C]formaldehyde | Q69833121 | ||
| Alzheimer's disease | Q69879466 | ||
| High dosage anticholinergic therapy in dystonia | Q72560936 | ||
| Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys | Q73145913 | ||
| Age-related reduction of [11C]MDL100,907 binding to central 5-HT(2A) receptors: PET study in the conscious monkey brain | Q73154145 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 248-257 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys | |
| P478 | volume | 41 |
| Q43959909 | Age differences in phosphodiesterase type-IV and its functional response to dopamine D1 receptor modulation in the living brain: a PET study in conscious monkeys |
| Q43764302 | Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys |
| Q44060478 | Age-related changes in the striatal dopaminergic system in the living brain: a multiparametric PET study in conscious monkeys |
| Q48241999 | An increase of sigma receptors in the aged monkey brain |
| Q53072429 | Development of novel PET probe [¹¹C](R,R)HAPT and its stereoisomer [¹¹C](S,S)HAPT for vesicular acetylcholine transporter imaging: a PET study in conscious monkey. |
| Q48099433 | Differential effects of stress on [11C]raclopride and [11C]MNPA binding to striatal D2/D3 dopamine receptors: A PET study in conscious monkeys |
| Q43825610 | Effects of aging on 5-HT(1A) receptors and their functional response to 5-HT(1a) agonist in the living brain: PET study with [carbonyl-(11)C]WAY-100635 in conscious monkeys |
| Q34988437 | Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys |
| Q34411638 | Normal genetic variation, cognition, and aging |
| Q51829340 | Validation of reference tissue model of PET ligand [11C](+)3‐MPB for the muscarinic cholinergic receptor in the living brain of conscious monkey |
Search more.